FDA identifies serious recall for Dexcom CGM mobile apps
The One+ offering with the sensor, app and receiver. [Image courtesy of Dexcom] The FDA identified a recent recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors (CGMs) as the most serious type. This recall involves correcting certain devices through a software update. It does not involve removing them from where they are used…